Oxford Finance LLC
Oxford Finance LLC provides senior debt and tailored credit solutions to companies worldwide, with stated sector focus on life sciences, healthcare services, healthtech, business services and software & technology. The firm reports serving over 700 companies and originating more than $14 billion in loans since 2002, with credit facilities ranging from $5 million to $200 million.
Oxford Finance LLC
Alexandria, Virginia, United States, North America
Services
Enterprise Lending
Bespoke loan solutions for healthtech, life sciences and SaaS borrowers across product development through commercial growth. Product types mentioned include term loans, revolvers and other structured senior debt facilities.
Leveraged Lending
Capital solutions for leveraged transactions and sponsor-backed platforms from transaction close through platform growth and exit. Roles include lead arranger and administrative agent on term loans, revolvers and delayed draw term loans (DDTL).
Real Estate & Asset-Based Lending (ABL)
Real estate and asset-based credit facilities tailored for healthcare services companies, including sole-lender credit facilities and asset-based revolvers or term loans.
Specialty Debt Products and Capital Markets Execution
Senior note offerings and other debt capital market financings (e.g., senior note offering referenced on site).
Enterprise Lending
Bespoke loan solutions for healthtech, life sciences and SaaS borrowers across product development through commercial growth. Product types mentioned include term loans, revolvers and other structured senior debt facilities.
Leveraged Lending
Capital solutions for leveraged transactions and sponsor-backed platforms from transaction close through platform growth and exit. Roles include lead arranger and administrative agent on term loans, revolvers and delayed draw term loans (DDTL).
Real Estate & Asset-Based Lending (ABL)
Real estate and asset-based credit facilities tailored for healthcare services companies, including sole-lender credit facilities and asset-based revolvers or term loans.
Specialty Debt Products and Capital Markets Execution
Senior note offerings and other debt capital market financings (e.g., senior note offering referenced on site).
Portfolio
$500,000,000 term loan; Brisbane, CA; NASDAQ: VERA
#Biopharmaceuticals / Life Sciences
$200,000,000 term loan; Cambridge, MA; NASDAQ: SRRK
#Biopharmaceuticals / Life Sciences
$150,000,000 term loan; San Diego, CA; NASDAQ: INBX
#Biopharmaceuticals / Life Sciences
$200,000,000 term loan; Altrincham, UK & Boston, MA; NASDAQ: CNTA
#Biopharmaceuticals / Life Sciences
$155,500,000 credit facility; sole lender; Georgia
#Healthcare services / Real estate
$47,000,000 term loan & revolver; sole lender; Texas
#Healthcare services
$500,000,000 term loan; Brisbane, CA; NASDAQ: VERA
#Biopharmaceuticals / Life Sciences
$200,000,000 term loan; Cambridge, MA; NASDAQ: SRRK
#Biopharmaceuticals / Life Sciences
$150,000,000 term loan; San Diego, CA; NASDAQ: INBX
#Biopharmaceuticals / Life Sciences
$200,000,000 term loan; Altrincham, UK & Boston, MA; NASDAQ: CNTA
#Biopharmaceuticals / Life Sciences
$155,500,000 credit facility; sole lender; Georgia
#Healthcare services / Real estate
$47,000,000 term loan & revolver; sole lender; Texas
#Healthcare services